Skip to main content

Advertisement

Fig. 1 | Radiation Oncology

Fig. 1

From: Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients

Fig. 1

Kaplan-Meier curve shows the (a) OS of the whole cohort of newly diagnosed GBM patients after surgical resection, with a median of 15.9 months. b The extent of resection correlated with OS: GTR 22.6 months, STR 14.9 months, and biopsy 12.1 months. c DXM use concurrent with RT was a poor prognostic indicator of OS (median 12.7 vs. 22.5 months, p = 0.02 by log-rank test). d For patients who underwent GTR, those who were treated with DXM had a median survival of 16.3 months compared to 24.6 months without DXM (p = 0.15 by log-rank test)

Back to article page